Monthly Buprenorphine Approved to Treat Opioid Addiction

The FDA has approved a monthly buprenorphine injection, marketed as Sublocade, to treat moderate-to-severe opioid use disorder. Other forms of the drug (e.g...

Source: Physician's First Watch current issue - December 4, 2017 Category: Primary Care Source Type: news